IQV Stock — Iqvia Holdings Inc.: Financials

Reported balance	As of	Amount	Source
Current portion of long-term debt	2026-06-30	USD 2,294,000,000	10-Q filed 2026-07-28
Noncurrent debt carrying amount	2026-06-30	USD 13,705,000,000	10-Q filed 2026-07-28
Noncurrent operating lease liabilities	2026-06-30	USD 242,000,000	10-Q filed 2026-07-28

4.625% senior notes due 2033

Note · IQVIA Inc.

Reference: 4.625% senior notes due 2033

Active

Original principal: EUR 950,000,000
Outstanding: —
Commitment: —
Availability: —
Maturity: Jun 15, 2033

Last reported interest terms: 4.625% Reported 2026-06-11 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history

Issuance · 8-K · 2026-06-11 — 8-K

Issuance · 2026-06-11 Original principal EUR 950,000,000 Exact source document Parent 8-K filing · 2026-06-11
On June 11, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc. (the “Company”), completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033 (the “Notes”).

Issuer evidence: On June 11, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc. (the “Company”), completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033 (the “Notes”).

Supporting evidence: The Notes are unsecured obligations of the Issuer, will mature on June 15, 2033, unless earlier repurchased or redeemed in accordance with their terms, and will bear interest at the rate of 4.625% per year, with interest payable semi-annually on June 15 and December 15 of each year, beginning on December 15, 2026.

Supporting evidence: On June 11, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc. (the “Company”), completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033 (the “Notes”).

Supporting evidence: On June 11, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc. (the “Company”), completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033 (the “Notes”).

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenue	+4.2%	+7.5%	+11.0%	$17.15B – $17.35B	$16.98B	$16.31B^G	$15.41B^G	$14.98B^G	$14.41B^G	$13.87B^G	$11.36B^G	$11.09B	$10.41B	$9.74B	$6.88B	$5.74B	$5.46B	$5.1B	$4.87B	$4.33B
Research & Development	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$3.34M	$5.79M	$4.96M	$10.43M	$9.99M
Selling, General & Administrative	-1.2%	+2.2%	+9.4%	—	$2.06B	$2B	$1.99B	$2.05B	$2.07B	$1.96B	$1.79B	$1.73B	$1.72B	$1.62B	$1.02B	$815M	$781M	$860.51M	$817.76M	$762.3M
Amortization of Intangibles	+0.5%	-3.1%	+30.8%	—	—	$984M	$965M	$974M	$970M	$1.12B	$1.15B	$1.07B	$1.02B	$886M	$210M	$67M	$58M	$51.45M	$46.44M	$35.55M
Depreciation & Amortization	+0.4%	-2.3%	+24.5%	—	$1.18B	$1.14B	$1.11B	$1.13B	$1.13B	$1.26B	$1.29B	$1.2B	$1.14B	$1.01B	$289M	$128M	$121M	$107.5M	$98.29M	$92M
Restructuring Charges	+55.4%	+15.1%	+13.3%	—	$158M	$105M	$67M	$84M	$28M	$20M	$52M	$75M	$68M	$63M	$71M	$30M	$9M	$14.07M	$18.74M	$22.12M
Operating Income	+6.6%	+24.4%	+12.9%	—	$2.2B	$2.18B	$2.2B	$1.98B	$1.8B	$1.39B	$731M	$777M	$741M	$665M	$576M	$646M	$590M	$462.33M	$396.44M	$345.25M
Operating Margin	—	—	—	—	—	13.38%	14.29%	13.19%	12.48%	10.04%	6.44%	7.01%	7.12%	6.83%	8.37%	11.26%	10.81%	9.07%	8.15%	7.98%
EBITDA	+4.3%	+10.5%	+15.7%	—	$3.38B	$3.33B	$3.32B	$3.1B	$2.93B	$2.66B	$2.02B	$1.98B	$1.88B	$1.68B	$865M	$774M	$711M	$569.84M	$494.72M	$437.26M
Interest Expense	+20.6%	+11.9%	+21.9%	—	$771M	$729M	$670M	$672M	$416M	$375M	$416M	$447M	$414M	$346M	$144M	$101M	$101M	$123.51M	-$134.37M	$109.07M
Interest Income	+51.3%	+49.6%	+27.4%	—	$41M	$45M	$47M	$36M	$13M	$6M	$6M	$9M	$8M	$7M	$4M	$4M	$4M	$3.94M	$3.07M	$3.94M
Other Non-Operating Income	—	+8.8%	—	—	$109M	$99M	$90M	$124M	-$33M	$130M	$65M	$37M	-$5M	-$13M	$11M	-$2M	$8M	$185K	$3.57M	-$9.07M
Equity in Earnings of Unconsolidated Entities	—	+25.7%	+10.6%	—	$59M	$22M	$5M	$0	-$12M	$6M	$7M	-$9M	$15M	$10M	-$4M	$8M	$5M	-$1.12M	$2.57M	$70.76M
Investment Income (Loss)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0	$5M	$0	$0	—
Pretax Income	+5.3%	+33.7%	+11.4%	—	$1.57B	$1.59B	$1.67B	$1.46B	$1.36B	$1.13B	$373M	$352M	$328M	$294M	$416M	$539M	$501M	$323.12M	$267.43M	$184.68M
Income Tax	-1.0%	+28.5%	+4.7%	—	$254M	$252M	$301M	$101M	$260M	$163M	$72M	$116M	$59M	-$992M	$325M	$159M	$149M	$95.97M	$93.36M	$15.11M
Net Income	+7.6%	+37.3%	+13.4%	—	$1.38B	$1.36B	$1.37B	$1.36B	$1.09B	$966M	$279M	$191M	$259M	$1.28B	$72M	$387M	$357M	$226.59M	$177.55M	$241.77M
Net Margin	—	—	—	—	—	8.34%	8.91%	9.06%	7.57%	6.96%	2.46%	1.72%	2.49%	13.11%	1.05%	6.75%	6.54%	4.44%	3.65%	5.59%
Net Income Attributable to Noncontrolling Interests	—	-49.0%	0.0%	—	$4M	$1M	$0	$0	$0	$5M	$29M	$36M	$25M	$19M	$15M	$1M	$118K	-$564K	-$915K	$1.45M
Comprehensive Income	+23.6%	+30.5%	+15.8%	—	$1.29B	$1.46B	$1.2B	$1.22B	$770M	$775M	$385M	$104M	-$14M	$1.89B	-$382M	$335M	$298M	$218.52M	$162.37M	$217.67M
EPS (Basic) USD/shares	+10.8%	+40.2%	+9.6%	—	$8.11	$7.91	$7.57	$7.39	$5.82	$5.05	$1.46	$0.98	$1.27	$5.86	$0.48	$3.15	$2.78	$1.83	$1.53	$2.08
EPS (Diluted) USD/shares	+11.1%	+40.5%	+9.8%	$12.80 – $13.00*	$8.04	$7.84^G	$7.49^G	$7.29^G	$5.72^G	$4.95^G	$1.43^G	$0.96	$1.24	$5.74	$0.47	$3.08	$2.72	$1.77	$1.51	$2.05
Shares Outstanding (Basic Avg) shares	-2.9%	-2.1%	+3.4%	—	—	171.9M	181.3M	183.8M	187.6M	191.4M	191.3M	195.1M	203.7M	217.8M	149.1M	123M	128M	124.15M	115.71M	116.23M
Shares Outstanding (Diluted Avg) shares	-3.1%	-2.3%	+3.3%	—	—	173.5M	183.4M	186.3M	190.6M	195M	195M	199.6M	208.2M	222.6M	152M	125.6M	131.1M	127.86M	117.8M	117.94M

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Research and Development Solutions	$8,896,000,000	$8,527,000,000	$8,395,000,000	$7,921,000,000	$7,556,000,000	$5,760,000,000	$5,788,000,000	$5,465,000,000
Technology and Analytics Solutions	$6,626,000,000	$6,160,000,000	$5,862,000,000	$5,746,000,000	$5,534,000,000	$4,858,000,000	$4,486,000,000	$4,137,000,000
Contract Sales and Medical Solutions	$788,000,000	$718,000,000	$727,000,000	$743,000,000	$784,000,000	$741,000,000	$814,000,000	$810,000,000

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Americas	$7,745,000,000	$7,356,000,000	$7,552,000,000	$7,048,000,000	$6,848,000,000	$5,419,000,000	$5,462,000,000	$4,998,000,000
EMEA	$5,185,000,000	$4,920,000,000	$4,459,000,000	$4,366,000,000	$4,357,000,000	$3,695,000,000	$3,477,000,000	$3,448,000,000
Asia Pacific	$3,380,000,000	$3,129,000,000	$2,973,000,000	$2,996,000,000	$2,669,000,000	$2,245,000,000	$2,149,000,000	$1,966,000,000

IQV · Iqvia Holdings Inc. · Financials

Chart any reported metric, KPI or segment over time — the full statement history lives here

Capital Returned to Shareholders

Debt Profile

Reported debt balances

Covenants

Loans, facilities and notes

4.625% senior notes due 2033

Price & Valuation

Valuation

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

By Segment (USD)

By Geography (USD)